Kentucky
Phase 1 cancer trials in Kentucky
44 Phase 1 cancer studies are recruiting participants at sites in 3 cities across Kentucky as of November 17, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Kentucky city with a recruiting study
By research area: Lung Cancer (20), Lymphoma (8), Breast Cancer (5), Melanoma (5), Pancreatic Cancer (5), Prostate Cancer (1).
Louisville (26), Lexington (18), Edgewood (2).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Breast cancer: recently updated in Kentucky
Basic details from each study's public record (the 12 most recently updated of 44). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- LigaChem Biosciences, Inc.
- Recruiting in
- Edgewood
- Registry record
- NCT06774963 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Kentucky on ClinicalTrials.gov.
Lung cancer: recently updated in Kentucky
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Lexington
- Registry record
- NCT06287775 · updated
DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Recruiting in
- Lexington
- Registry record
- NCT07707895 · updated
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Edgewood
- Registry record
- NCT07227597 · updated
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Inhibrx Biosciences, Inc
- Recruiting in
- Louisville
- Registry record
- NCT04198766 · updated
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Recruiting in
- Lexington
- Registry record
- NCT07397338 · updated
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Obsidian Therapeutics, Inc.
- Recruiting in
- Louisville
- Registry record
- NCT06060613 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Kentucky on ClinicalTrials.gov.
Melanoma: recently updated in Kentucky
A Study of BI 3810944 in Patients With Advanced Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Recruiting in
- Louisville
- Registry record
- NCT07224425 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Kentucky on ClinicalTrials.gov.
Lymphoma: recently updated in Kentucky
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Recruiting in
- Lexington · Louisville
- Registry record
- NCT04726241 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Kentucky on ClinicalTrials.gov.
Pancreatic cancer: recently updated in Kentucky
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Lexington
- Registry record
- NCT05372614 · updated
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- RayzeBio, Inc.
- Recruiting in
- Lexington
- Registry record
- NCT07165132 · updated
Lead-212 PSV359 Therapy for Patients With Solid Tumors
- Phase 1/2
- Ages 18 to 90
- All sexes
- Sponsor
- Perspective Therapeutics
- Recruiting in
- Lexington
- Registry record
- NCT06710756 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Kentucky on ClinicalTrials.gov.
Ask about studies in Kentucky
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections